Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Flow Nasal Cannula Versus Conventional Oxygen to Prevent Hypoxaemia During Awake Tracheal Intubation: A Multicentre, Open-Label, Randomised Controlled Trial (OXYOPTI-ATI)

NCT07384494 is registered in ClinicalTrials.gov with Wenxian Li as lead sponsor.

NCT NCT07384494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07384494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Flow Nasal Cannula Versus Conventional Oxygen to Prevent Hypoxaemia During Awake Tracheal Intubation: A Multicentre, Open-Label, Randomised Controlled Trial (OXYOPTI-ATI)
Lead sponsor
Wenxian Li
Phase
Not applicable
Overall status
Recruiting
Start date
February 4, 2026
Completion date
December 31, 2026
Enrollment
336 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

awake tracheal intubation, difficult airway